Table 3.
|
Percentage of Sp100-associated nuclear dots per cell (n = 300) |
||
---|---|---|---|
Time after IFN-β treatment (h) | ≤2 | ≥3≤4 | ≥5 |
0 | 85 | 9 | 6 |
4 | 76 | 15 | 9 |
8 | 62 | 22 | 16 |
16 | 49 | 19 | 32 |
24 | 20 | 18 | 62 |
|
Percentage of Sp100-associated nuclear dots per cell (n = 300) |
||
---|---|---|---|
Time after IFN-β treatment (h) | ≤2 | ≥3≤4 | ≥5 |
0 | 85 | 9 | 6 |
4 | 76 | 15 | 9 |
8 | 62 | 22 | 16 |
16 | 49 | 19 | 32 |
24 | 20 | 18 | 62 |